Pharmaceutical (Market Access)

 

In August 2002, the Canadian Life and Health Insurance Association published Protection from Severe Drug Expenses, a study carried out by Fraser Group and Tristat Resources.

The report is available for download in a PDF file format.

English (3,677 kb)
Français (3,854 kb)

The purpose of this study was to evaluate the extent to which Canadians are protected by their public and private sector drug programs from severe drug expense. This research was presented to the Senate Committee on Social Affairs, Science and Technology and was cited extensively in their final report on the The Health of Canadians - The Federal Role.

In March 2000, Health Canada published Canadians' Access to Insurance for Prescription Medicines, the results of a study carried out by Fraser Group in collaboration with two other companies, Applied Management and Tristat Resources.

The purpose of this study was to assess the level of drug insurance available to Canadians.

The report is available for download in a PDF file format below.


Executive Summary (81 kb)
Volume 1: Range and Extent of Coverage (2633 kb)
Volume 2: The Un-Insured and Under-Insured (1874 kb)

Français
Sommaire (74 kb)
This page was last updated on May 27, 2009 by hz.
Site Development by Technicalities